Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
Símbolo de cotizaciónVTAK
Nombre de la empresaCatheter Precision Inc
Fecha de salida a bolsaSep 27, 2018
Fundada en2018
Director ejecutivoMr. David A. Jenkins
Número de empleados22
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 27
Dirección1670 Highway 160 West
CiudadFORT MILL
Bolsa de valoresNYSE American Consolidated
PaísUnited States of America
Código postal29708
Teléfono19736912000
Sitio Webhttps://www.ramed.com/
Símbolo de cotizaciónVTAK
Fecha de salida a bolsaSep 27, 2018
Fundada en2018
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos